Enliven Therapeutics
ELVN
#5218
Rank
NZ$1.95 B
Marketcap
$41.28
Share price
5.84%
Change (1 day)
80.91%
Change (1 year)

Enliven Therapeutics (ELVN) - Total debt

Total debt on the balance sheet as of June 2024 : NZ$0.27 M

According to Enliven Therapeutics's latest financial reports the company's total debt is NZ$0.27 M. A companyโ€™s total debt is the sum of all current and non-current debts.

Enliven Therapeutics - Total debt on balance sheet (from 2021 to 2024)

Total debt by year

Year Total debt Change
2023-12-31NZ$0.52 M4.13%
2022-12-31NZ$0.5 M119.12%
2021-12-31NZ$0.23 M59.03%
2020-12-31NZ$0.14 M